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Background
Vaccination with live attenuated SIV confers potent pro-
tection against wild-type challenge, although correlates
of adaptive immunity have not been reliably demon-
strated. Despite safety concerns for this vaccine
approach in humans, understanding the mechanism of
this protection may inform and guide HIV vaccine
design. In Mauritian-origin cynomolgus macaques
(Macaca fascicularis), we have demonstrated early,
potent protection against the heterologous SIVsmE660
virus stock following vaccination with the minimally
attenuated SIVmac251/C8 vaccine [1]. Failure to associ-
ate correlates of protection with adaptive immune
responses and the emergence of protection as early as 3
weeks post vaccination has led us to characterise anti-
retroviral innate immune responses in this model
system.
Materials and methods
The distribution and level of intracellular virus replica-
tion in multiple lymphoid tissues including the small
and large intestine, spleen, inferior and superior mesen-
teric lymph nodes (i and sMLN) was determined by
quantitative PCR (qPCR) over a time-course of 3, 7, 10,
21 and 125 days following vaccination with live attenu-
ated SIVmacC8. Virus presence in the same tissues was
also confirmed by in-situ hybridisation. To evaluate
aspects of the innate immune response, TRIM5a geno-
type was determined and transcriptome analysis per-
formed by qPCR for multiple ínterferon-inducing and
induced genes including IRF-7, STAT-1, TRIM5a,
ApoBEC3G, tetherin, TRIM-22. In addition, a range of
immunological markers of cell-surface protein expres-
sion were measured by immunohistochemistry.
Results
Following SIV inoculation, rapid and widespread disse-
mination of virus was identified in multiple lymphoid
tissues. The MLN represented the site with the most
consistent frequency of virus infection, with virus
detected at 3 days post-infection. Transcriptome analysis
indicated a significant up-regulation of TRIM5a,A p o -
BEC3G and IRF-7 with the highest levels co-inciding
with the peak of primary viraemia at day 10. Subse-
quently, responses tended to follow the control of acute-
phase replication beyond day 21 which remained above
baseline levels at day 125. Retrospective analysis of pro-
tective vaccine studies indicates raised cell-surface mar-
kers of mediators of innate immunity including CD68+
macrophages, and S100 and DC-SIGN on dendritic cells
which were upregulated and maintained in vaccinated,
protected macaques but diminished in cases of retroviral
superinfection.
Conclusions
These data suggest a broad anti-retroviral innate
response generated during primary SIV infection, driven
in this instance by live retrovirus vaccination with a nef-
disrupted virus. These appear to be playing a role in
controlling the vaccine virus, co-incident with wide-
spread changes in cell-population dynamics previously
described for this vaccine [2] which are maintained
above basal levels by a persistent virus replicating in
multiple lymphoid tissues. The relative contribution of
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